Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
nbix | 0.25 | 0.4 | 409 | 10 | 4 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
nbix | 1.89 | 0.2 | 7634 | 70 |
https://finance.yahoo.com/quote/NBIX
WebFind the latest Neurocrine Biosciences, Inc. (NBIX) stock quote, history, news and other vital information to help you with your stock trading and investing.
DA: 18 PA: 77 MOZ Rank: 49
https://www.neurocrine.com/
WebBrave. Science ®. Our purpose is to relieve suffering for people with great needs, but few options. Three Decades of Discovery. Our dedication to discovery remains unwavering after more than 30 years of investigating potential life-changing treatments for patients with neurological, neuroendocrine, and neuropsychiatric disorders.
DA: 73 PA: 79 MOZ Rank: 70
https://www.google.com/finance/quote/NBIX:NASDAQ
WebGet the latest Neurocrine Biosciences, Inc. (NBIX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...
DA: 67 PA: 92 MOZ Rank: 80
https://www.bloomberg.com/quote/NBIX:US
Web2 days ago · View Your Watchlist. Stock analysis for Neurocrine Biosciences Inc (NBIX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
DA: 2 PA: 82 MOZ Rank: 27
https://www.marketwatch.com/investing/stock/NBIX
WebApr 12, 2024 · kr88.7M. NBIX | Complete Neurocrine Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
DA: 41 PA: 58 MOZ Rank: 39
https://finance.yahoo.com/news/neurocrine-biosciences-nbix-reports-next-140138122.html
Web1 day ago · Neurocrine Biosciences (NBIX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus ...
DA: 90 PA: 88 MOZ Rank: 62
https://seekingalpha.com/symbol/NBIX
Web6 days ago · A high-level overview of Neurocrine Biosciences, Inc. (NBIX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
DA: 73 PA: 32 MOZ Rank: 92
https://www.nasdaq.com/market-activity/stocks/nbix
WebNeurocrine Biosciences, Inc. Common Stock (NBIX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
DA: 83 PA: 21 MOZ Rank: 15
https://www.wsj.com/market-data/quotes/NBIX
WebView the latest Neurocrine Biosciences Inc. (NBIX) stock price, news, historical charts, analyst ratings and financial information from WSJ.
DA: 3 PA: 58 MOZ Rank: 15
https://stockanalysis.com/stocks/nbix/
Web2 days ago · Get a real-time Neurocrine Biosciences, Inc. (NBIX) stock price quote with breaking news, financials, statistics, charts and more.
DA: 44 PA: 29 MOZ Rank: 51
https://neurocrine.gcs-web.com/
WebMar 28, 2024 · Neurocrine Biosciences has four commercial, FDA-approved treatments in the United States and a robust pipeline. Annual Reports. Stock Quote. (Common Stock) Change. Volume. 52 Week High. 52 Week Low. 04/16/24 7:42 AM EDT. Data Provided by Refinitiv. Minimum 15 minutes delayed. Latest Filings. Data provided by Kaleidoscope. …
DA: 65 PA: 77 MOZ Rank: 49
https://www.morningstar.com/stocks/XNAS/NBIX/quote
Web6 days ago · Neurocrine Biosciences Inc NBIX. Morningstar Rating. Unlock. Stock XNAS Rating as of Apr 19, 2024. Summary. Chart. News. Price vs Fair Value. Sustainability. Trailing Returns. Financials....
DA: 84 PA: 51 MOZ Rank: 22
https://seekingalpha.com/news/4092737-neurocrine-stock-gains-depression-trial-win
Web1 day ago · According to NBIX, one dose showed an improvement over the placebo, while the other dose indicated a trend toward improvement on days 28 and 26. The study drug was well tolerated, with the most ...
DA: 52 PA: 71 MOZ Rank: 20
https://finance.yahoo.com/quote/NBIX/profile
WebSee the company profile for Neurocrine Biosciences, Inc. (NBIX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key...
DA: 42 PA: 42 MOZ Rank: 99
https://finviz.com/quote.ashx?t=NBIX
WebNeurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders.
DA: 55 PA: 93 MOZ Rank: 15
https://www.prnewswire.com/news-releases/neurocrine-biosciences-receives-breakthrough-therapy-designation-from-us-food-and-drug-administration-for-crinecerfont-in-congenital-adrenal-hyperplasia-302006430.html
WebSAN DIEGO, Dec. 5, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced it received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA)...
DA: 67 PA: 33 MOZ Rank: 77
https://www.nasdaq.com/articles/neurocrines-phase-2-savitri-study-meets-primary-endpoint-for-nbi-1065845-in-adults-with
Web2 days ago · (RTTNews) - Neurocrine Biosciences, Inc. (NBIX) announced positive results on Tuesday from its Phase 2 SAVITRI trial, which evaluated the effectiveness and safety of NBI-1065845 in adult patients ...
DA: 68 PA: 11 MOZ Rank: 86
https://www.zacks.com/stock/news/2261295/neurocrine-biosciences-nbix-reports-next-week-wall-street-expects-earnings-growth
Web1 day ago · Neurocrine Biosciences (NBIX Quick Quote NBIX - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March ...
DA: 85 PA: 79 MOZ Rank: 57
https://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-fda-approval-of-ingrezza-valbenazine-capsules-for-the-treatment-of-chorea-associated-with-huntingtons-disease-301904823.html
WebSAN DIEGO, Aug. 18, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration (FDA) has approved INGREZZA ® (valbenazine) capsules for...
DA: 55 PA: 23 MOZ Rank: 22
https://markets.businessinsider.com/news/stocks/analysts-offer-insights-on-healthcare-companies-neurocrine-nbix-healthstream-hstm-and-vertex-pharmaceuticals-vrtx-1033282907
Web1 day ago · Neurocrine (NBIX) Canaccord Genuity analyst Sumant Kulkarni maintained a Buy rating on Neurocrine yesterday and set a price target of $154.00. The company’s shares closed last Tuesday at $140.09 ...
DA: 82 PA: 94 MOZ Rank: 45
https://www.barchart.com/stocks/quotes/NBIX
WebAnnual Income, $ 249,700 K. 60-Month Beta 0.25. Price/Sales 6.96. Price/Cash Flow 51.39. Price/Book 5.83. Trade NBIX with: Price/Earnings ttm 54.55. Earnings Per Share ttm 2.42. Most Recent Earnings $1.44 on 02/07/24. Latest Earnings Date 05/01/24. Annual Dividend & Yield N/A (0.00%) Most Recent Dividend N/A on N/A. Sectors:
DA: 38 PA: 76 MOZ Rank: 48
https://finance.yahoo.com/quote/NBIX/news/
WebNeurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its first quarter 2024 financial results conference call and webcast for 5:00 a.m. Pacific Time (8:00 a.m....
DA: 74 PA: 25 MOZ Rank: 82
https://www.neurocrine.com/our-company/news-and-media/feature-link/investor-relations/
WebNeurocrine Biosciences, Inc. (Nasdaq: NBIX) financial results for the second quarter ended June 30, 2022 and reiterated financial guidance for 2022. Learn More >
DA: 91 PA: 15 MOZ Rank: 63
https://www.nasdaq.com/market-activity/stocks/nbix/latest-real-time-trades
WebNBIX Latest Real Time Trades Data is currently not available. Select time range to see more trades: Last 100 Trades. Last 100 Trades 09:30 - 09:59 10:00 ...
DA: 95 PA: 32 MOZ Rank: 12
https://www.marketbeat.com/stocks/NASDAQ/NBIX/
Web6 days ago · NASDAQ:NBIX. Neurocrine Biosciences (NBIX) Stock Price, News & Analysis. → With the “Bitcoin Loophole” you can supercharge the gains by 10x or more (From DTI) Free NBIX Stock Alerts. $132.00. -0.54 (-0.41%) (As of 04/19/2024 ET) Compare. Today's Range. $130.13. . $133.65. 50-Day Range. $130.40. . $143.74. 52 …
DA: 76 PA: 9 MOZ Rank: 59
https://www.neurocrine.com/pipeline/
WebA Robust. Pipeline. Powered. by Brave. Science. Areas of investigation include potential new treatments in neurology, neuroendocrinology, and neuropsychiatry. Our Pipeline. We have a robust pipeline of investigational therapies with the potential to address unmet clinical needs of patients. Neurology. Neuroendocrinology. Neuropsychiatry.
DA: 74 PA: 54 MOZ Rank: 47
https://www.marketbeat.com/instant-alerts/nasdaq-nbix-earnings-date-2024-04-24/
Web1 day ago · Neurocrine Biosciences ( NASDAQ:NBIX - Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Wednesday, May 1st. Analysts expect Neurocrine Biosciences to post earnings of $1.04 per share for the quarter. Parties interested in participating in the company's conference call can do so using this link.
DA: 26 PA: 83 MOZ Rank: 91
https://finance.yahoo.com/quote/NBIX/history
WebLNTH Lantheus Holdings, Inc. +2.37% Discover historical prices for NBIX stock on Yahoo Finance. View daily, weekly or monthly format back to when Neurocrine Biosciences, Inc. stock was issued.
DA: 59 PA: 48 MOZ Rank: 10
https://www.linkedin.com/company/nimbix/
WebNimbix is the leading #HPC #cloud platform provider. Since July 30, 2021, Nimbix is part of Atos. View all 14 employees. About us. Nimbix is the leading provider of purpose-built cloud...
DA: 14 PA: 46 MOZ Rank: 91